In this role, Jeffrey DeAlmeida takes responsibility for BASF’s global pharmaceutical solutions portfolio and the Nutrition & Health business in North and South America
Study to evaluate effectiveness of hypoglossal nerve stimulation
Keytruda plus Lenvima is also approved in the U.S. and Europe for the first-line treatment of adult patients with advanced RCC.
Industry leaders discusses the need of innovation for the Indian drug industry at BioAsia 2022.
Cataract is the most common cause of blindness in India, and that diabetes is to be blamed for the massive number of damaged eyes
New inhalers would have near-zero Global Warming Potential propellant
US $ 555,000 invested by Wavemaker Partners in pre-seed round
Application based on the pivotal Phase 3 TRANSFORM study in which Breyanzi showed significant and clinically meaningful improvements over salvage chemotherapy followed by high-dose chemotherapy plus autologous stem cell transplant, which has been the standard of care for more than 20 years
New subsidiaries to be established in Malaysia, Taiwan, Singapore, and Hong Kong
Key takeaways of Q3FY22 quarter & conference call highlights
Subscribe To Our Newsletter & Stay Updated
